Recent developments

at Tullis and our portfolio companies

News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

June

2

Tullis Health Investors Welcomes Bob Crutchfield to Its Team

Tullis Health Investors is pleased to announce the addition of Robert L. Crutchfield as...

14

electroCore Announces First Quarter Financial Results

Generated first quarter revenue of $734,000 Secured FDA clearance of gammaCore™ (nVNS) label expansion for migraine...

11

Exagen Inc. Reports First Quarter 2020 Results

AVISE® Testing Volumes Increase with Retention Rate of 99% SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE)...

11

ATEC Reports First Quarter 2020 Financial Results And Recent Corporate Highlights

• New Product Adoption Drives U.S. Revenue Growth of 27%• Additional $35 Million Capital...

29

electroCore Provides Update on COVID-19 Clinical Initiatives

Randomized controlled investigator-initiated trial (IIT) of non-invasive vagus nerve stimulation (nVNS) therapy currently enrolling...

27

ATEC Terminates Agreement To Acquire EOS Imaging

Ongoing Impacts of COVID-19 Pandemic Constitute “Material Adverse Effect” Company Intends to Explore Other...

7

OrthoSensor Receives 510(k) Alignment Clearance For VERASENSE To Be Used With Zimmer Biomet’s Persona Knee System

In a prospective multi-center study, VERASENSE use was proven to reduce post-operative pain, accelerate...

25

Exagen Inc. Reports Fourth Quarter and Full Year 2019 Results

AVISE® Testing Revenue Drives 24% Revenue Growth SAN DIEGO, March 25, 2020 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq:...

24

Exagen Appoints Chief Medical and Chief Scientific Officers

The additions of Debra Jeske Zack, M.D., Ph.D., as CMO, and Anja Kammesheidt, Ph.D.,...

16

Exagen Inc. Partners with Sonora Quest Laboratories to Offer AVISE Testing for Patients Suspected of Autoimmune Disease

Testing can facilitate improved care through the differential diagnosis, prognosis, monitoring and therapeutic optimization...

9

Exagen Inc. Partners with Three California Medical Groups to Offer AVISE Testing as Covered In-Network Benefit for Their Patients

AVISE testing can facilitate improved care through the differential diagnosis, prognosis, management, and therapeutic...

5

ATEC Reports Fourth Quarter And Full Year 2019 Financial Results

U.S. Revenue Grew Nearly 30% Year-Over-Year for the Full YearAnd 35% Year-Over-Year in the Fourth...

Recent developments

News

June

2

Tullis Health Investors Welcomes Bob Crutchfield to Its Team

May

14

electroCore Announces First Quarter Financial Results

May

11

Exagen Inc. Reports First Quarter 2020 Results

May

11

ATEC Reports First Quarter 2020 Financial Results And Recent Corporate Highlights

April

29

electroCore Provides Update on COVID-19 Clinical Initiatives

April

27

ATEC Terminates Agreement To Acquire EOS Imaging

April

7

OrthoSensor Receives 510(k) Alignment Clearance For VERASENSE To Be Used With Zimmer Biomet’s Persona Knee System

March

25

Exagen Inc. Reports Fourth Quarter and Full Year 2019 Results

March

24

Exagen Appoints Chief Medical and Chief Scientific Officers

March

16

Exagen Inc. Partners with Sonora Quest Laboratories to Offer AVISE Testing for Patients Suspected of Autoimmune Disease

March

9

Exagen Inc. Partners with Three California Medical Groups to Offer AVISE Testing as Covered In-Network Benefit for Their Patients

March

5

ATEC Reports Fourth Quarter And Full Year 2019 Financial Results